Afuco™ Anti-PA ADCC Recombinant Antibody (Obiltoxaximab), ADCC Enhanced (CAT#: AFC-TAB-440CQ)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to PA. Obiltoxaximab is a chimeric (mouse/human) monoclonal antibody that can be potentially used in the treatment of Anthrax inhalation.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Bacillus anthracis anthraxtoxin protective antigen (PA)
  • Species Reactivity
  • Bacillus anthracis
  • Clone
  • Obiltoxaximab
  • Applications
  • ELISA, IHC, FC, IP, IF, FuncS
  • Conjugate
  • Unconjugated
  • Generic Name
  • Obiltoxaximab
  • Related Disease
  • Anthrax inhalation

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • PA; Bacillus anthracis anthraxtoxin protective antigen

Related Resources

  • Biosimilar Overview
Please refer to Obiltoxaximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Obiltoxaximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Obiltoxaximab"

Anti-Bacillus Anthracis PA Recombinant Antibody (Obiltoxaximab)
Recombinant monoclonal antibody to PA. Obiltoxaximab is a chimeric (mouse/human) monoclonal antibody that can be potentially used in the treatment of Anthrax inhalation.

See other products for "B. anthracis PA"

Single-domain Antibody

CAT Product Name Application Type
NAB-194-VHH Recombinant Anti-B. anthracis PA VHH Single Domain Antibody WB, ICC, ChiP, FA, ELISA Llama VHH

Human Antibody

CAT Product Name Application Type
TAB-224 Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab) FC, IP, ELISA, Neut, FuncS, IF, WB IgG1 - lambda

Epitope-Specific Antibody

CAT Product Name Application Type
EPAF-0387LC Recombinant Mouse Anti-B. anthracis PA Antibody (F20G75) BL, ELISA IgG1

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-224 Afuco™ Anti-B. anthracis PA ADCC Recombinant Antibody (Raxibacumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-440CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare